Clinical Trial Update: Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine [Phase 4]

View source ↗

Summary

Phase 4 safety and immunogenicity assessment of a liquid pentavalent DTP-HepB-Hib vaccine completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• Pentavalent DTP-HepB-Hib vaccine (liquid) (Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus influenzae type b pentavalent vaccine)

Snippet

Sponsor: Shantha Biotechnics Limited | Conditions: Diphtheria, Tetanus | Phase 4 | Status: COMPLETED